EV/EBITDA
-3.14
+0.08+2.48%
10 min ago
Summary:
KalVista Pharmaceuticals EV/EBITDA is currently -3.14, with a rise of +0.08 (+2.48%) during the most recent trading day. Over the past year, it has dropped by -1.13 (-56.22%). KALV EV/EBITDA is now -310.74% below its all-time high of 1.49.KALV EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KALV EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | +2.5% |
| 1 m1 month | +5.1% |
| 3 m3 months | +14.0% |
| 6 m6 months | +12.0% |
| ytdytd | +12.8% |
| 1 y1 year | -56.2% |
| 5 y5 years | +52.1% |
KALV EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | -2.84 | -10.6% | -3.83 | +18.0% |
| 3 m | 3 months | -2.62 | -19.9% | -3.83 | +18.0% |
| 6 m | 6 months | -2.62 | -19.9% | -4.90 | +35.9% |
| 1 y | 1 year | -1.94 | -61.9% | -4.95 | +36.6% |
| 3 y | 3 years | -0.72 | -336.1% | -4.95 | +36.6% |
| 5 y | 5 years | -0.72 | -336.1% | -20.76 | +84.9% |
| alltime | all time | 1.49 | -310.7% | -22.62 | +86.1% |
KalVista Pharmaceuticals EV/EBITDA History
| Date | Value |
|---|---|
| 2024 | -3.14(-12.8%) |
| 2023 | -3.60(+88.5%) |
| 2022 | -1.91(-50.8%) |
| 2021 | -3.88(-42.4%) |
| 2020 | -6.74(-17.8%) |
| Date | Value |
|---|---|
| 2019 | -8.20(-29.1%) |
| 2018 | -11.56(+265.8%) |
| 2017 | -3.16(+92.7%) |
| 2016 | -1.64(-16.3%) |
| 2015 | -1.96 |
FAQ
- What is KalVista Pharmaceuticals EV/EBITDA?
- What is the all time high EV/EBITDA for KalVista Pharmaceuticals?
- What is KALV EV/EBITDA year-to-date change?
- What is KalVista Pharmaceuticals EV/EBITDA year-on-year change?
What is KalVista Pharmaceuticals EV/EBITDA?
The current EV/EBITDA of KALV is -3.14
What is the all time high EV/EBITDA for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high EV/EBITDA is 1.49
What is KALV EV/EBITDA year-to-date change?
KalVista Pharmaceuticals EV/EBITDA has changed by +0.46 (+12.78%) since the beginning of the year
What is KalVista Pharmaceuticals EV/EBITDA year-on-year change?
Over the past year, KALV EV/EBITDA has changed by -1.13 (-56.22%)